Atropos Health
Rapidly provides personalized real-world evidence for any clinical decision.
| USD | 2022 | 2023 |
|---|---|---|
| Revenues | 0000 | 0000 |
| % growth | - | 331 % |
| EBITDA | 0000 | 0000 |
| Profit | 0000 | 0000 |
| EV | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 |
Source: Dealroom estimates
Related Content
Atropos Health operates in the healthcare technology sector, focusing on providing personalized real world evidence to physicians. The company addresses the 'Evidence Gap' in clinical research, which arises when randomized control trials (RCTs) exclude significant patient populations. Atropos Health's core product is a digital consultation service that leverages observational research and proprietary technology developed over five years at Stanford University. This service enables physicians to answer complex clinical questions within 24 hours by rapidly querying patient data. The business model is based on offering subscription-based access to its consultation services, targeting healthcare providers, hospitals, and research institutions. Revenue is generated through these subscriptions and potentially through partnerships with pharmaceutical companies and other stakeholders in the healthcare ecosystem.
Keywords: personalized evidence, clinical decisions, real world data, physician consultation, observational research, healthcare technology, evidence gap, rapid data queries, Stanford University, subscription model.